Leading the Way in Life Science Technologies

GEN Exclusives

More »

October 1, Vol. 25, No. 17

  • Feature Articles

    • Contract Manufacturing Fills Industry Niche
    • Auxilium Pharmaceuticals (wwwauxiliumcom) and Cobra Biomanufacturing (wwwcobrabiocom) recently signed an agreement for the scale up and GMP manufacture of Phase II/III clinical supplies of Auxilium's AA4500, a novel protein drug and potential treatment of Peyronie's disease and Dupuytren's disease The ... more »
    • Linking Discovery Data to Diagnostics
    • Elizabeth Lipp
    • As biomarker research and development gains traction, many companies seek to accomplish a couple goals: to distinguish oneself from competitors, and to refine the means of targeting diseases and their associated genes to maximize their R&D dollar... more »
    • Biotechnology in Australia and New Zealand
    • Longtime archrivals on the cricket and rugby fields, New Zealand and Australia have begun to look beyond competition toward collaborating for the sake of biotechnology In June 2005, AgResearch (Auckland), New Zealand's chief livestock research agency and part of the ... more »
  • Columns

    • Proposition for a New and Better Model for Healt...
    • I can not be the only person a little disappointed and frustrated with the fragmentation, volatility, and short-termism of what society calls its current global strategic agendas In some cases these agendas seem to be at best, self-interested, in others, ... more »
    • Diabetes: Potential Breakthroughs in Therapy
    • Type 2 diabetes is a growing epidemic with an estimated 182 million people affected in the US and 194 million worldwide as of 2002 Prevalence has increased steadily in the past 20 years, and over one million new cases are ... more »